Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors.
暂无分享,去创建一个
C. Heldin | K. Pietras | E. Buchdunger | R. Reed | M. Sjöquist | K. Rubin | A. Ostman | A. Östman | Rolf K. Reed
[1] R. Reed,et al. Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of 51Cr‐EDTA , 2000, International journal of cancer.
[2] C. Heldin,et al. Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Fischman,et al. Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Siegbahn,et al. Cell interactions with collagen matrices in vivo and in vitro depend on phosphatidylinositol 3-kinase and free cytoplasmic calcium. , 1998, Cell adhesion and communication.
[5] H. Eichler,et al. Interstitial methotrexate kinetics in primary breast cancer lesions. , 1998, Cancer research.
[6] F. Yuan,et al. Transvascular drug delivery in solid tumors. , 1998, Seminars in radiation oncology.
[7] K. Rubin,et al. Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells. , 1997, The American journal of pathology.
[8] T. Helbich,et al. 5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. , 1997, Cancer research.
[9] R. Reed,et al. Integrins and control of interstitial fluid pressure. , 1997 .
[10] K. Giercksky,et al. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report , 1996, Cancer Chemotherapy and Pharmacology.
[11] Nebojsa Janjic,et al. Inhibitory DNA ligands to platelet-derived growth factor B-chain. , 1996, Biochemistry.
[12] R. Reed,et al. A novel physiological function for platelet‐derived growth factor‐BB in rat dermis. , 1996, The Journal of physiology.
[13] R. K. Jain,et al. Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts. , 1996, British Journal of Cancer.
[14] D. Mendrick,et al. Colon‐cancer cell variants producing regressive tumors in syngeneic rats, unlike variants yielding progressive tumors, attach to interstitial collagens through integrin α2β1 , 1996, International journal of cancer.
[15] R K Jain,et al. Delivery of Molecular Medicine to Solid Tumors , 1996, Science.
[16] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[17] L. Påhlman,et al. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[18] K. Rubin,et al. Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. , 1993, The American journal of pathology.
[19] R. Jain,et al. Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft. , 1993, Cancer research.
[20] R. Jain,et al. Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. , 1992, Cancer research.
[21] J. Double,et al. A critical appraisal of the predictive value of in vitro chemosensitivity assays. , 1990, Journal of the National Cancer Institute.
[22] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[23] R K Jain,et al. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.
[24] C. Heldin,et al. cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules , 1988, Molecular and cellular biology.
[25] R K Jain,et al. Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.
[26] F. A. Meyer,et al. Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (umbilical cord). , 1983, Biochimica et biophysica acta.
[27] P. Sejrsen,et al. Transcapillary exchange of 14C-inulin by free diffusion in channels of fused vesicles. , 1977, Acta physiologica Scandinavica.
[28] P. Gullino,et al. THE INTERSTITIAL FLUID OF SOLID TUMORS. , 1964, Cancer research.
[29] C. Heldin,et al. Involvement of platelet-derived growth factor in disease: development of specific antagonists. , 2001, Advances in cancer research.
[30] B. Druker,et al. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. , 2000, The Journal of clinical investigation.
[31] N. Janjić,et al. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. , 1999, The American journal of pathology.
[32] T. Meyer,et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. , 1996, Cancer research.
[33] T. Borg,et al. Molecular recognition of the extracellular matrix by cell surface receptors. , 1996 .
[34] B. Haraldsson,et al. Transport of macromolecules across microvascular walls: the two-pore theory. , 1994, Physiological reviews.
[35] R. Reed,et al. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. , 1993, Physiological reviews.
[36] R. Reed,et al. Interstitial fluid pressure in DMBA-induced rat mammary tumours. , 1982, Scandinavian journal of clinical and laboratory investigation.